Medicine

C. Hughes, T. Nichols, Martin Pike, C. Subbe, Salah Elghenzai

2020.4.29European Journal of Case Reports in Internal Medicine

DOI: 10.12890/2020_001691

tlooto Summary

Clinicians should carefully consider the risk of thrombosis in patients positive for COVID-19, including prophylaxis and treatment beyond discharge, as well as consider the risks of stroke, venous thromboembolism, pulmonary embolism and cardiac complications.

Abstract

Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the case of a 59-year-old man who presented with headache, hypertension and a single episode of fever with no other symptoms. He subsequently developed unilateral weakness. Computer tomography identified a cerebral venous sinus thrombosis (CVST). A subsequent test for COVID-19 was positive. This is the first report of CVST as a presenting symptom of COVID-19 infection. LEARNING POINTS Thrombotic events may be the initial presenting symptom of COVID-19. These thrombotic events include stroke, venous thromboembolism, pulmonary embolism and cardiac complications. Clinicians should carefully consider the risk of thrombosis in patients positive for COVID-19, including prophylaxis and treatment beyond discharge.

Citation format

HUGHES, C., et al. Cerebral venous sinus thrombosis as a presentation of COVID-19. European Journal of Case Reports in Internal Medicine, 2020, 7.